J F Haeuw
Overview
Explore the profile of J F Haeuw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beck A, Goetsch L, Champion T, Bussat M, Aubry J, Klinguer-Hamour C, et al.
Biologicals
. 2002 Feb;
29(3-4):293-8.
PMID: 11851331
The decapeptide ELA (ELAGIGILTV), a Melan-A/MART-1 antigen immunodominant peptide analogue, is an interesting melanoma vaccine candidate alone or in combination with other tumour antigens. P40, the recombinant outer membrane protein...
2.
Goetsch L, Gonzalez A, Haeuw J, Aubry J, Beck A, Bonnefoy J, et al.
Infect Immun
. 2001 Sep;
69(10):6434-44.
PMID: 11553588
Administration of vaccines by the nasal route has recently proven to be one of the most efficient ways for inducing both mucosal and systemic antibody responses in experimental animals. Our...
3.
Dagouassat N, Robillard V, Haeuw J, Power U, Corvaia N, Nguyen T, et al.
Vaccine
. 2001 Jul;
19(30):4143-52.
PMID: 11457539
Human respiratory syncytial virus (hRSV) is a major pathogen responsible for bronchiolitis and severe pulmonary disease in very young children, immunodeficient patients and the elderly. BBG2Na, a recombinant chimeric protein...
4.
Beck A, Bussat M, Klinguer-Hamour C, Goetsch L, Aubry J, Champion T, et al.
J Pept Res
. 2001 Jul;
57(6):528-38.
PMID: 11437956
Several cytotoxic T lymphocyte peptide-based vaccines against hepatitis B, human immunodeficiency virus and melanoma were recently studied in clinical trials. One interesting melanoma vaccine candidate alone or in combination with...
5.
Goetsch L, Aubry J, Haeuw J, Bonnefoy J, Nguyen N, Corvaia N, et al.
Vaccine
. 2001 Jun;
19(28-29):4036-42.
PMID: 11427280
Respiratory syncytial virus (RSV) is a major respiratory pathogen responsible for severe pulmonary disease. We have developed a parenterally administered vaccine, BBG2Na, which is currently in a phase III clinical...
6.
Dagouassat N, Haeuw J, Robillard V, Damien F, Libon C, Corvaia N, et al.
J Immunol Methods
. 2001 Apr;
251(1-2):151-9.
PMID: 11292490
We have developed and validated a process-specific immunoligand assay based on the Threshold system for the quantification of residual host cell proteins (HCPs) in a recombinant subunit vaccine candidate against...
7.
Power U, Goetsch L, Champion T, Beck A, Haeuw J, Nguyen T, et al.
Vaccine
. 2001 Mar;
19(17-19):2345-51.
PMID: 11257359
Respiratory syncytial virus (RSV) is an important respiratory pathogen in man, against which no vaccine is available. However, recent evidence suggests that antibodies to the RSV F and G proteins...
8.
Miconnet I, Coste I, Beermann F, Haeuw J, Cerottini J, Bonnefoy J, et al.
J Immunol
. 2001 Mar;
166(7):4612-9.
PMID: 11254719
The recent identification of tumor Ags as potential vaccines has prompted the search for efficient adjuvants and delivery systems, especially in the case of peptide-based vaccination protocols. Here, we investigated...
9.
Haeuw J, Libon C, Zanna L, Goetsch L, Champion T, Nguyen T, et al.
Dev Biol (Basel)
. 2001 Feb;
103:245-50.
PMID: 11214244
No abstract available.
10.
Beck A, Zorn N, Bussat M, Haeuw J, Corvaia N, Nguyen T, et al.
Dev Biol (Basel)
. 2001 Feb;
103:231-6.
PMID: 11214240
Respiratory Syncytial Virus (RSV) is the most important cause of bronchiolitis and viral pneumoniae in infants and young children. Approximately 100,000 children are hospitalized in the USA each year as...